RE: Broker option12 May 2020 08:52
Agreed Technick. Now what can they they use that £8M for?
The net proceeds of the Fundraising will support the rapid development of the Genedrive® SARS-CoV-2 assays, fund the scale-up of the Genedrive-96-SARS-CoV-2 test including build-up of inventory for an initial period, fund product development, commercialisation and general corporate purposes.
Let’s get on with it!